GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.

Inclusion Criteria:

• PATIENTS WITH T2DM:
• Diagnosed with type 2 diabetes by a healthcare professional
• Currently being treated with insulin medication, excluding premix insulin treatment
• Age at least 40 years
• Diagnosed as having type 2 diabetes over the age of 40
• HCPs:
• Primary care physician, diabetes specialist (diabetologist/endocrinologist) or diabetes specialist nurse/diabetes nurse educator
• Have a minimum of 2 years experience within current speciality
• See a minimum of 20 type 2 diabetes patients per month (40 for diabetes specialists), of which at least 10 per month must be on modern (analogue) inulins